The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study.

AIMS To assess changes in coronary heart disease (CHD) event rates and CHD mortality rates among diabetic and non-diabetic individuals between two large study cohorts with baseline assessments 10 years apart and followed up for 10 years. METHODS AND RESULTS Four population surveys were carried out in 1972, 1977, 1982, and 1987 in a randomly selected independent population in Finland. For the analyses, we combined the 1972 and 1977 cohorts (cohort 1) and similarly also the 1982 and 1987 cohorts (cohort 2). A total of 16 779 men and 18 235 women were followed up for 10 years. Whereas the risk of first cardiovascular disease event in women did not change between the two cohorts, the risk in diabetic men aged 25-49 years and men of all age groups with incidence diabetes during the follow-up decreased compared with the earlier cohort. The relative risk of CHD mortality in men with baseline diabetes or incident diabetes compared with non-diabetic individuals increased (from 1.67 to 1.75 and 1.00 to 1.92, respectively). CHD event rates and CHD mortality rates decreased among non-diabetic individuals between the two study cohorts. CONCLUSION Special attention should be given to prevent the onset of diabetes in the population and to intensify the management of patients with diabetes.

[1]  A. Dobson,et al.  Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations , 2000, The Lancet.

[2]  E. Feskens,et al.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.

[3]  G. Schernthaner Cardiovascular mortality and morbidity in type-2 diabetes mellitus. , 1996, Diabetes research and clinical practice.

[4]  E. Vartiainen,et al.  Serum cholesterol distribution and coronary heart disease risk: observations and predictions among middle-aged population in eastern Finland. , 1998, Circulation.

[5]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[6]  T. Thom International mortality from heart disease: rates and trends. , 1989, International journal of epidemiology.

[7]  Richard Barnett,et al.  Diabetes mellitus. , 1993, The Medical journal of Australia.

[8]  J. Medalie,et al.  Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. , 1993, Cardiology.

[9]  Roberto Ferrari,et al.  The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. , 2004, European heart journal.

[10]  Diabetes mellitus. Report of a WHO Study Group. , 1985, World Health Organization technical report series.

[11]  J. Leahy Mortality Trends in Men and Women with Diabetes, 1971 to 2000 , 2008 .

[12]  J. Tuomilehto,et al.  The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. , 2005, Journal of the American College of Cardiology.

[13]  V. Salomaa,et al.  The feasibility of routine mortality and morbidity register data linkage to study the occurrence of acute coronary heart disease events in Finland , 2000, European Journal of Epidemiology.

[14]  Principal Investigators,et al.  The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collabaration , 1988 .

[15]  J. Tuomilehto,et al.  Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction , 2005, Diabetologia.

[16]  E. Vartiainen,et al.  Fifteen-year trends in coronary risk factors in Finland, with special reference to North Karelia. , 1991, International journal of epidemiology.

[17]  S. Haffner Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes. , 1999, Diabetes care.

[18]  V. Salomaa,et al.  Trends in coronary events in Finland during 1983-1997. The FINAMI study. , 2003, European heart journal.

[19]  S Kumanyika,et al.  Obesity prevention: the case for action , 2002, International Journal of Obesity.

[20]  J. Medalie Risk Factors Other Than Hyperglycemia in Diabetic Macrovascular Disease , 1979, Diabetes Care.

[21]  J. Tuomilehto,et al.  Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. , 2005, Diabetes care.

[22]  R. Holman,et al.  Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) , 1998, BMJ.

[23]  K. Narayan,et al.  Mortality Trends in Men and Women with Diabetes, 1971 to 2000 , 2007, Annals of Internal Medicine.

[24]  Pd redaction Oświadczenie w sprawie konfliktu interesów , 2001 .

[25]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[26]  E. Vartiainen,et al.  Trends and determinants of ischaemic heart disease mortality in Finland: with special reference to a possible levelling off in the early 1980s. , 1989, International journal of epidemiology.

[27]  V. Salomaa,et al.  Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study. , 1996, Circulation.

[28]  H. A. Kahn,et al.  Statistical Methods in Epidemiology , 1989 .

[29]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[30]  W. Bell,et al.  Extensive thrombus formation with heparin resistance during extracorporeal circulation. A new presentation of familial antithrombin III deficiency. , 1987, Archives of internal medicine.

[31]  E. Vartiainen,et al.  Role of known risk factors in explaining the difference in the risk of coronary heart disease between eastern and southwestern Finland. , 1998, Annals of medicine.

[32]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[33]  E. Vartiainen,et al.  Twenty-Year Dynamics of Serum Cholesterol Levels in the Middle-Aged Population of Eastern Finland , 1996, Annals of Internal Medicine.

[34]  Kudva Bt On diabetes mellitus. , 1984 .

[35]  L. Kuller,et al.  Coronary artery disease in IDDM. Gender differences in risk factors but not risk. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[36]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[37]  L. Melton,et al.  Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. , 2003, Archives of internal medicine.

[38]  V. Salomaa,et al.  Impact of Diabetes on Mortality After the First Myocardial Infarction , 1998, Diabetes Care.

[39]  William G. Cochran,et al.  Sampling Techniques, 3rd Edition , 1963 .

[40]  J. Medalie,et al.  Angina pectoris among 10,000 men. 5 year incidence and univariate analysis. , 1973, The American journal of medicine.

[41]  J. Medalie,et al.  Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. , 1976, The American journal of medicine.

[42]  B. Howard,et al.  Diabetes and cardiovascular disease , 2000, Annual review of medicine.

[43]  J. Tuomilehto,et al.  Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? , 2003, Diabetes care.

[44]  Daniel L. McGee,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[45]  J. Tuomilehto,et al.  Post-challenge hyperglycaemia is associated with premature death and macrovascular complications , 2003, Diabetologia.

[46]  E. Vartiainen,et al.  Trends in cardiovascular disease risk factor clustering in eastern Finland: results of 15-year follow-up of the North Karelia Project. , 1994, Preventive medicine.

[47]  Ralph B D'Agostino,et al.  Trends in cardiovascular complications of diabetes. , 2004, JAMA.

[48]  J. Sowers,et al.  Diabetes and cardiovascular disease. , 1999, Diabetes care.

[49]  E. Feskens,et al.  Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.